Daily non-political popular news in brief.
Pre-operative high or low red blood cell count linked with poorer outcomes in older patients
06-12-2007 · EurekAlert!Older patients with mild degrees of pre-operative anemia -- low red blood cell count -- or those with a very high red blood cell count have a higher risk of post-operative death or cardiac events following major noncardiac surgery, according to a study in the June 13 issue of JAMA.
Read more »
Keywords: pre-operative, low, red, blood, cell, count, linked, poorer, outcomes, older, patients, pre, operative, outcome, patient
« Previous | Next »
Similar news on "Pre-operative high or low red blood cell count linked with poorer outcomes in older patients":
- Red cells count: Study shows pre-op levels affect post-op outcomes
06-12-2007 · EurekAlert!
Elderly men with even slightly abnormal red blood cell counts have a higher risk of dying or having a serious cardiac event after major surgery, according to a new study conducted by researchers at the Providence Veterans Affairs Medical Center and the Warren Alpert Medical School of Brown University. Results are published in JAMA.
Similar news · Read more »
- Pre-treatment blood test could guide lung cancer therapy
06-05-2007 · EurekAlert!
A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has developed a new pre-treatment blood test that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies (Iressa, Tarceva). The mass spectrometry-based test, described in the June 6 Journal of the National Cancer Institute, may allow physicians to select the most beneficial therapy for each lung cancer patient, a step forward in the era of personalized medicine.
Similar news · Read more »
- A new way to boost red blood cell numbers
01-10-2008 · EurekAlert!
A common treatment for anemia is administration of recombinant erythropoietin, a hormone that stimulates the production of rbc precursors by the bone marrow. Unfortunately, many patients with anemia do not respond to treatment with Epo. However, a new study in mice has indicated that the protein Gas6 might have valuable therapeutic potential for the treatment of individuals with anemia who fail to respond to treatment with Epo.
Similar news · Read more »
- Better assessment of transfusions could save blood
02-06-2007 · EurekAlert!
Nearly 95 percent of patients admitted to hospital intensive care units are affected by anemia. Consequently, these patients receive a large number of red blood cell (RBC) transfusions in order to restore proper hemoglobin levels. New research shows that alternative treatments may lead to fewer transfusions, conserving critical blood supplies in hospitals. The report is published in Seminars in Dialysis.
Similar news · Read more »
- Gene variations associated with effectiveness of blood pressure medications
01-22-2008 · EurekAlert!
Patients with hypertension and certain gene variations experienced varying results with some blood pressure medications, suggesting matching a patient's genotype with certain hypertension medications could result in more favorable outcomes, according to a study in the Jan. 23 issue of JAMA.
Similar news · Read more »
- Insights into anemia control in dialysis patients
07-11-2007 · EurekAlert!
Anemia is one of the most frequent complications of hemodialysis, and its correction is an important factor in restoring a tolerable quality of life to dialysis-dependent patients. Treatment with drugs called erythropoiesis-stimulating agents (ESAs), which stimulate the bone marrow to produce red blood cells, have been a major advance in the treatment of the anemia (low levels of red blood cells or hemoglobin, which carries oxygen in the blood) in chronic kidney disease (CKD).
Similar news · Read more »
- Eltrombopag effective for hepatitis C patients with low blood-platelet counts
12-28-2007 · EurekAlert!
For patients with hepatitis C, having a low blood platelet count is a frequent complication associated with advanced disease. This problem is compounded by the fact that standard antiviral treatment for the disease can further reduce platelet numbers to dangerously low levels, effectively denying these patients the treatment they urgently need. Now, research published in the New England Journal of Medicine finds that a new drug, eltrombopag, appears to significantly boost platelet counts, opening the door to effective treatment.
Similar news · Read more »
- Low vitamin E levels associated with physical decline in elderly
01-22-2008 · EurekAlert!
Researchers at Yale School of Medicine have found that a low concentration of vitamin E in the blood is linked with physical decline in older persons.
Similar news · Read more »
- Due to cost, heart attack patients often avoid follow-up care and medication
03-13-2007 · EurekAlert!
A lack of funds to pay for medical treatment and prescriptions is common among heart attack patients and leads to a worse recovery, more angina, poorer quality of life and higher risk of re-hospitalization, according to a study by researchers at Yale School of Medicine. Published in the March 14 issue of Journal of the American Medical Association (JAMA), the study sought to determine if self-reported financial barriers to health care services or medication were associated with worse patient outcomes.
Similar news · Read more »
- New choices for patients: Transfusion-free medicine for Jehovah's Witnesses and transfusion-wary
12-05-2007 · EurekAlert!
Transfusion-free Medicine for Jehovah's Witnesses and Patients Wary of Blood Transfusions was pioneered at Pennsylvania Hospital Center for Bloodless Medicine and Surgery in Philadelphia. Bloodless medicine practices have shown outcomes that can benefit the entire patient community, including shorter hospital stays, and the elimination of transfusion-related complications. Pennsylvania Hospital is part of the University of Pennsylvania Health System.
Similar news · Read more »
